Category
Healthcare

Hims & Hers Dives on FDA Crackdown, Sending Shockwaves Through Weight-Loss Drug Trade
Hims & Hers (HIMS) took a steep dive after U.S. regulators signaled an aggressive move against compounded versions of blockbuster weight-loss medicines, shaking investor confidence in one of the fastest-growing corners of digital health.

UnitedHealth Stock Falls as Medicare Surprise Sparks Broad Insurer Selloff
Shares of UnitedHealth Group (UNH) took a dive on Tuesday, leading a broad selloff across the health insurance sector after the Trump administration announced a surprise proposal that limits future Medicare Advantage payment growth.

Nanox’s Bold $800K Bet: Can VasoHealthcare IT Jumpstart U.S. AI Imaging?
Nanox’s planned acquisition of VasoHealthcare IT signals a strategic push to speed U.S. adoption of its AI imaging tech by adding nationwide integration, data migration, and deployment expertise.

Community Health Systems In Play: Why Tenor Health Foundation Could Be Circling This Small-Cap Hospital Operator!
CYH advances divestiture strategy, selling 3 PA hospitals to Tenor Health Foundation. Deal aligns with leverage reduction and turnaround plan, spotlighting CYH’s value in underserved markets.

Avanos Medical Could Be WRS Group’s Next Big Buy: Is A Small-Cap Orthopedic Play On The Move?
Avanos Medical’s sale of its Game Ready unit to WRS Group sharpens focus on core pain and nutrition lines, streamlining operations and sparking fresh acquisition interest.

DocGo’s Bold SteadyMD Acquisition Sends Shares Flying—What’s Next?
DocGo buys virtual care platform SteadyMD in an all-cash deal, boosting its digital health reach. The move excites investors as DocGo gains growth, profit potential, and key new leadership.

Talkspace Just Acquired Wisdo—Here’s What It Means For Mental Health AI!
ChatGPT said: Talkspace acquires Wisdo Health to strengthen its AI-driven behavioral health platform, adding peer-based support and expanding reach across major healthcare markets.

HealthStream’s Virsys12 Buy Signals A Strategic Shift Toward The Payer Market!
HealthStream acquires Virsys12 for $17M, expanding into the payer market with V12 Enterprise® and strengthening its credentialing suite as it shifts toward a broader healthcare platform strategy.

Zepp Health's Bet On Women’s Health With The Wild.AI Buyout: Strategic Leap Or Risky Play?
Zepp Health, best known for its Amazfit smartwatches, has taken a bold step in health-tech with its acquisition of Wild.AI’s core assets and IP—a leading platform in women’s wellness.

Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments?
Phreesia is charting new territory with its recently announced $160 million all-cash acquisition of AccessOne Parent Holdings, a healthcare financing firm with a receivables portfolio of $450 million.

Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape
Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share, valuing the deal at approximately $412 million.

Waystar’s $1.25 Billion AI Bet: Can The Iodine Deal Supercharge Its Growth Engine?
Waystar, a leading healthcare payments platform, has announced its plan to acquire health AI company Iodine Software for $1.25 billion in a mix of cash and stock.

DexCom’s Bold Type 2 Bet Could Reshape The Glucose Monitoring Market—What It Means for Investors!
DexCom has undergone a major strategic reset after a turbulent 2024, and all eyes are now on its bold shift toward the vastly underpenetrated Type 2 diabetes market.

Hims & Hers Stock Plunges After Novo Nordisk Breakup: What Really Happened?
Hims & Hers Health saw its stock crash by over 35% in a matter of days after Novo Nordisk announced the termination of its short-lived partnership over the weight loss drug Wegovy.

Healthcare Stocks: Once a Safe Bet, Healthcare Now Faces New Market Headwinds
Healthcare stocks have long been considered a safe and reliable bet for investors seeking stability during turbulent times.

Healthcare Stocks: Thriving Amidst Economic Uncertainty
Despite economic concerns, the sell-off in big tech, rising interest rates and a looming recession, healthcare stocks are still going strong.

Skylight Health Executes Definitive Agreement to Acquire NeighborMD to Expand in Florida and Enters Medicare Advantage Global Risk
Skylight executes a definitive agreement for the largest acquisition to date and secured a US $20 million credit line facility to fund the acquisition and future deals NeighborMD (“NMD”) adds 9 practices across Central and Southern Florida with over 2,400 owned and affiliated global capitated risk lives. Trailing 12 months (TTM) primary care revenue of ...

Healthcare Triangle Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
HITRUST Risk-based, 2-year Certification validates Healthcare Triangle is committed to meeting key regulations and protecting sensitive information PLEASANTON, Calif., April 20, 2022 – Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the "Company"), a leading provider of cloud and data transformation solutions for healthcare and life sciences, today annou

These Eye Problems Could Be Symptoms Of COVID-19 Coronavirus
Looks like the eyes may have it. You know those round things that sit below your forehead and you use to “wink and gun” at people? Well, add them to the growing list of body parts that may be affected by the COVID-19 coronavirus. A study recently published in JAMA Ophthalmology found that 31.6% of 38 consecutive patients with COVID-19 ...

NanoKnife FDA Approval Is The Highlight Of An Otherwise Tepid AngioDynamics Quarter
Latham, New York: AngioDynamics, Inc. (NASDAQ:ANGO) is a number one supplier of modern, minimally invasive medical units utilized by skilled healthcare suppliers for vascular entry, peripheral vascular illness, and oncology. It just lately reported its monetary outcomes for the third quarter of the fiscal 12 months 2019 ending 28th February 19 whereby the co
Lexicon’s Volatility Could Be Your Friend After The Zynquista Rejection
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is an organization identified for locating novel drug targets and drug candidates developed from state-of-the-art medicinal chemistry and proprietary gene. The firm lately produced a superb outcome beating Wall Street expectations with the administration anticipating a 20% income development in 2019, pushed by Euro

Women’s Health Player, Establishment Labs Witnesses Rising Implant Sales; Delivers Mixed Results
New York, NY: Establishment Labs Holdings Inc. (NASDAQ:ESTA), is a world medical know-how firm centered on ladies’s health, within the breast aesthetics and reconstruction market, by designing, growing, manufacturing and advertising an revolutionary portfolio of silicone gel-filled breast implants. It not too long ago reported monetary outcomes for the fourt

Amphastar Had A Good 2018 With Multiple ANDA Approvals
Rancho Cucamonga, CA: Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) is a specialty pharmaceutical firm that focuses totally on creating, manufacturing, advertising, and promoting technically-challenging generic and proprietary injectable, inhalation, intranasal merchandise, and insulin API merchandise. It launched its outcomes for the fourth quarter and full

Aerie Pharmaceuticals Delivers Mixed Result; Focus On International Expansion
Durhan, NC: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a scientific stage pharmaceutical firm targeted on offering therapies for the therapy of eye-related illnesses, launched its quarterly outcomes for the interval ended December 31,2018. The firm delivered its third consecutive blended outcome with a income beat however with an earnings miss. The administr
The Cancer Research Collaboration Partners with Diabetes Prevention Program Provider Blue Mesa Health with California Residents in Mind Nasdaq:RDNT
NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) — The Cancer Research Collaboration (CRC), a non-profit group devoted to increasing the supply of cutting-edge most cancers analysis, in partnership with RadNet, Inc. (Nasdaq:RDNT), a nationwide market chief offering high-quality, cost-effective diagnostic imaging providers by a community of fully-owned and oper
Sienna Announces December Dividend Toronto Stock Exchange:SIA.TO
[ad_1] MARKHAM, Ontario, Dec. 14, 2018 (GLOBE NEWSWIRE) — Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) at the moment introduced a dividend of $0.0765 per frequent share of the Company (every, a “Common Share”) for the month of December 2018, representing $0.918 per Common Share on an annualized foundation. The dividend can ...

Evitrade Health Systems (EVA-CNX) Setting Up to be the Breakout Stock of 2018
Disclaimer :This is a paid advertisement and all individuals should verify all claims and perform their own due diligence on EVA (and / or any other mentioned companies and / or securities), and read this disclaimer in its entirety.Small Cap Exclusive profiles are not a solicitation or recommendation to buy, sell or hold securities. Small...